Genomics

Merck hands over $20M in IBD target deal with Quotient

After generating interest from Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co.

Fraiser Kansteiner Mar 24, 2026 6:00am

A ballpoint pen rests on top of a stack of documents ready for signing

Boehringer continues kidney dealmaking with $120M Variant pact

Jan 6, 2026 10:45am

Leader of National Human Genome Research Institute put on leave

Apr 1, 2025 10:13am

UPDATE: Another NIH leader is out amid Trump admin shake-up

Mar 21, 2025 10:44am

Illumina maps out entry into spatial transcriptomics

Feb 20, 2025 11:00am

Saudi Arabia sets sights on becoming a biotech hub

Jan 25, 2024 10:38am